Table 3. Distribution of findings by imaging at the time of tumour marker increase.
| Patients | |
|---|---|
| Detected lesions, N (%) | N=44 (100) |
| Distant metastasesa | 29 (65.9) |
| Local recurrenceb | 1 (2.3) |
| Secondary malignancies | 6 (13.6) |
| Benign lesions | 9 (20.5) |
| Metastatic sites, N (%) | N=29 (100) |
| Bone | 18 (62.1) |
| Liver | 8 (27.6) |
| Lung | 7 (24.1) |
| Lymph node | 12 (41.4) |
| Others | 11 (37.9) |
| Visceral diseasec | 12 (41.4) |
| Only bone lesions | 10 (34.5) |
| Numbers of metastatic sites, N (%) | N=29 (100) |
| 1 organ | 14 (48.3) |
| 2 organs | 7 (24.1) |
| >2 organs | 8 (27.6) |
| Limited diseased | 7 (24.1) |
| Diffuse metastatic disease | 20 (69.0) |
| Secondary malignancies, N (%) | N=6 (100) |
| Ovarian cancere | 2 (33.3) |
| Uterine cancer | 1 (16.7) |
| Gastric cancer | 1 (16.7) |
| Non-small cell lung cancer | 1 (16.7) |
| Multiple myeloma | 1 (16.7) |
| Carcinoma of the parotid gland | 1 (16.7) |
| Benign lesions, N (%) | N=9 (100) |
| Benign lesion of the lung | 1 (11.1) |
| Benign lymph node | 1 (11.1) |
| Breast implant rupture | 2 (22.2) |
| Pancreatitis | 1 (11.1) |
| Cyst of the ovarian | 1 (11.1) |
| Diarrhoea | 1 (11.1) |
| No evidence of disease | 2 (22.2) |
a
The liver metastases of one patient were detected 6 months later in follow-up imaging.
b
One patient had both local recurrence and a secondary malignancy.
c
Involvement of the lung and/or liver.
d
Less than four malignant lesions to a single organ.
e
One patient had both an primary cancer of the uterine and an ovarian cancer.